NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 48 filers reported holding NEOS THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $983,000 | -29.1% | 149,343 | 0.0% | 0.34% | -39.5% |
| Q2 2016 | $1,386,000 | -14.0% | 149,343 | 0.0% | 0.55% | -17.2% |
| Q1 2016 | $1,611,000 | -24.7% | 149,343 | 0.0% | 0.67% | +11.1% |
| Q4 2015 | $2,139,000 | -48.9% | 149,343 | -25.1% | 0.60% | -24.8% |
| Q3 2015 | $4,188,000 | – | 199,343 | – | 0.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DSC Advisors, L.P. | 1,043,770 | $7,620,000 | 2.51% |
| Stonepine Capital Management, LLC | 565,100 | $4,125,000 | 2.23% |
| DAFNA Capital Management LLC | 209,873 | $1,532,000 | 1.09% |
| Ghost Tree Capital, LLC | 500,000 | $3,650,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,459,195 | $10,652,000 | 0.57% |
| PURA VIDA INVESTMENTS, LLC | 150,000 | $1,095,000 | 0.44% |
| J. Goldman & Co LP | 845,000 | $6,169,000 | 0.33% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 191,729 | $1,400,000 | 0.20% |
| Opaleye Management Inc. | 50,000 | $365,000 | 0.15% |
| HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | 50,000 | $365,000 | 0.15% |